Nomura Holdings Inc Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Nomura Holdings Inc

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $3.97 Million - $4.82 Million	-4,500 Reduced 18.83%	19,400 $20.4 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $21.6 Million - $23.7 Million	23,900 New	23,900 $23 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $10.4 Million - $11.8 Million	13,400 Added 2233.33%	14,000 $12.3 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $2.08 Million - $2.53 Million	-3,000 Reduced 83.33%	600 $493,000
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $420,018 - $498,210	600 Added 20.0%	3,600 $2.59 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $2.04 Million - $2.48 Million	3,000 New	3,000 $2.47 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.